Safer sleep for mom, safer start for baby? anesthesia study aims to protect premature newborns

NCT ID NCT02029898

Summary

This study looked at whether using a specific, short-acting pain medication (remifentanil) for mothers during emergency C-sections for premature births is safe for the baby's first critical minutes. Researchers compared babies whose mothers received this medication to those whose mothers did not, focusing on the baby's breathing, heart rate, and overall condition right after birth. The goal was to find the best way to manage the mother's pain while minimizing any potential risks to the fragile newborn.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CESAREAN SECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CHU de Rouen

    Rouen, 76031, France

Conditions

Explore the condition pages connected to this study.